Ces Urol 2024, 28(3):141-157 | DOI: 10.48095/cccu2024021

Methods of metaphylaxis in patients with different types of urolithiasis

Jiřina Marešová1, Jiří Kočárek1, 2, 3, Milan Čermák1, 2
1 Urologické oddělení, Oblastní nemocnice Kladno, a. s.
2 Urologická klinika, 1. LF UK a ÚVN, Praha
3 Urologická klinika, 3. LF a FNKV, Praha

Marešová J, Kočárek J, Čermák M. Methods of metaphylaxis in patients with different types of urolithiasis. The authors present the epidemiology, risk factors contributing to the development of urolithiasis, laboratory examination in lithiatic patients, including the analysis of the composition of concrements and its significance. The main goal of the article is to present the methods of non-invasive treatment of different types of lithiasis, especially metaphylaxis in patients with lithiasis, both regimen measures and the use of drugs that contribute to reducing the frequency of recurrences of lithiasis, as well as complications associated with this disease

Keywords: Urolithiasis, metaphylaxis, hypercalciuria, hyperoxaluria, hyperuricosuria, cystinuria, dihydroxyadenine, xanthine.

Received: May 27, 2024; Revised: August 7, 2024; Accepted: August 7, 2024; Prepublished online: August 13, 2024; Published: October 1, 2024 

Open full article

References

  1. Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol [Internet]. 2017; 35(9): 1301-1320. Available from: http://dx.doi.org/10.1007/s00345-017-2008-6. Go to original source... Go to PubMed...
  2. Qian X, Wan J, Xu J, et al. Epidemiological Trends of Urolithiasis at the Global, Regional, and National Levels: A Population-Based Study. Int J Clin Pract [Internet]. 2022; 2022: 1-12. Available from: http://dx.doi.org/10.1155/2022/6807203. Go to original source... Go to PubMed...
  3. Kočvara R, Drlík M. Dětská urologie. Praha: Maxdorf. Jessenius. 2023. ISBN 978-80-7345-740-2.
  4. Drabiščák E, Dorko E, Vargovčák M, et al. Analysis of potential risk factors associated with urolithiasis. Cent Eur J Public Health [Internet]. 2022; 30(Supplement): S37-42. Available from: http://dx.doi.org/10.21101/cejph.a6812. Go to original source... Go to PubMed...
  5. Osther PJS. Epidemiology of kidney stones in the European union. In: Urolithiasis. London: Springer London; 2012: p. 3-12. Available from: http://dx.doi.org/10.1007/978-1-4471-4387-1_1. Go to original source...
  6. Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol [Internet]. 2007; 177(1): 31-8. Available from: http://dx.doi.org/10.1016/j.juro.2006. 08. 088. Go to original source...
  7. Hellman N. What are Randall's plaques? [Internet]. Renal Fellow Network. 2008 [cited 2024 Aug 8]. Available from: https://www.renalfellow.org/2008/09/24/what-are-randalls-plaques.
  8. Trinchieri A. Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab. 2008; 5(2): 101-6.
  9. Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: "Give me your stone, I will tell you who you are!" World J Urol [Internet]. 2015; 33(2): 157-69. Available from: http://dx.doi.org/10.1007/s00345-014-1444-9. Go to original source... Go to PubMed...
  10. Zhu S, Fan Y, Hu X, Shao M. Insights into risk factors for urolithiasis: a mendelian randomization study. BMC Urol [Internet]. 2023; 23(1). Available from: http://dx.doi.org/10.1186/s12894-023-01243-4. Go to original source... Go to PubMed...
  11. Eisner BH, Ahn J, Stoller ML. Differentiating primary from secondary hyperparathyroidism in stone patients: The "thiazide challenge." J Endourol [Internet]. 2009; 23(2): 191-2. Available from: http://dx.doi.org/10.1089/end.2008.0567. Go to original source... Go to PubMed...
  12. Dessombz A, Letavernier E, Haymann J-P, Bazin D, Daudon M. Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis. J Urol [Internet]. 2015; 193(5): 1564-9. Available from: http://dx.doi.org/10.1016/j.juro.2014. 12. 017. Go to original source...
  13. Leslie SW, Sajjad H, Bashir K. 24-hour urine testing for nephrolithiasis: Interpretation and treatment guidelines. StatPearls Publishing; 2024.
  14. Riaz AP. Summary urine Normal Values, their significance [Internet]. Labpedia.net. 2021 [cited 2024 Aug 8]. Available from: https://labpedia.net/summary-urine-normal-values-their-significance.
  15. Prezioso D, Di Martino M, Galasso R, Iapicca G. Laboratory assessment. Urol Int [Internet]. 2007; 79(Suppl. 1): 20-5. Available from: http://dx.doi.org/10.1159/000104437. Go to original source... Go to PubMed...
  16. Kowalczyk NS, Zisman AL. Focus: Rare disease: Cystinuria: Review of a life-long and frustrating disease. The Yale Journal of Biology and Medicine. 2021; 94(4): 681.
  17. Das P, Gupta G, Velu V, at al. Formation of struvite urinary stones and approaches towards the inhibition-A review. Biomed Pharmacother [Internet]. 2017; 96: 361-70. Available from: http://dx.doi.org/10.1016/j.biopha.2017. 10. 015. Go to original source...
  18. Dion R. The urinary sediment. [Internet]. Connexence.com. [cited 2024 Aug 8]. Available from: http://urine.optmq.connexence.com/Imdoceng/d25d001.html.
  19. Begun FP, Foley WD, Peterson A, White B. Patient evaluation. Laboratory and imaging studies. Urol Clin North Am [Internet]. 1997; 24(1): 97-116. Available from: http://dx.doi.org/10.1016/s0094-0143(05)70357-8. Go to original source... Go to PubMed...
  20. Porena M, Guiggi P, Micheli C. Prevention of stone disease. Urol Int [Internet]. 2007; 79(Suppl. 1): 37-46. Available from: http://dx.doi.org/10.1159/000104440. Go to original source... Go to PubMed...
  21. Semins MJ, Matlaga BR. Medical evaluation and management of urolithiasis. Therapeutic Advances in Urology. 2010; 2(1): 3-9. doi:10.1177/1756287210369121. Go to original source... Go to PubMed...
  22. Letavernier E, Daudon M. Vitamin D, hypercalciuria and kidney stones. Nutrients [Internet]. 2018; 10(3): 366. Available from: http://dx.doi.org/10.3390/nu10030366. Go to original source... Go to PubMed...
  23. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol [Internet]. 2001; 12(9): 1986-93. Available from: http://dx.doi.org/10.1681/asn.v1291986. Go to original source... Go to PubMed...
  24. Heilberg IP, Schor N. Renal stone disease: causes, evaluation and medical treatment. Arq Bras Endocrinol Metabol [Internet]. 2006; 50(4): 823-31. Available from: http://dx.doi.org/10.1590/s0004-27302006000400027. Go to original source... Go to PubMed...
  25. Bleich HL, Boro ES, Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med [Internet]. 1974; 291(25): 1344-50. Available from: http://dx.doi.org/10.1056/nejm197412192912510. Go to original source... Go to PubMed...
  26. Ferraro PM, Bargagli M. Dietetic and lifestyle recommendations for stone formers. Arch Esp Urol. 2021; 74(1): 112-22.
  27. Yachantha C, Hossain RZ, Yamakawa K, et al. Effect of potassium depletion on urinary stone risk factors in Wistar rats. Urol Res [Internet]. 2009; 37(6): 311-6. Available from: http://dx.doi.org/10.1007/s00240-009-0220-6. Go to original source... Go to PubMed...
  28. Witting C, Langman CB, Assimos D, et al. Pathophysiology and treatment of Enteric hyperoxaluria. Clin J Am Soc Nephrol [Internet]. 2021; 16(3): 487-95. Available from: http://dx.doi.org/10.2215/cjn.08000520. Go to original source... Go to PubMed...
  29. Lorenz EC, Lieske JC, Seide BM, et al. Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant. Am J Transplant [Internet]. 2014; 14(6): 1433-8. Available from: http://dx.doi.org/10.1111/ajt.12706. Go to original source... Go to PubMed...
  30. Michael M, Groothoff JW, Shasha-Lavsky H, et al. Lumasiran for advanced primary hyperoxaluria type 1: Phase 3 ILLUMINATE-C trial. Am J Kidney Dis [Internet]. 2023; 81(2): 145-155.e1. Available from: http://dx.doi.org/10.1053/j.ajkd.2022. 05. 012. Go to original source...
  31. Perazella MA, Herlitz LC. The crystalline nephropathies. Kidney Int Rep [Internet]. 2021; 6(12): 2942-57. Available from: http://dx.doi.org/10.1016/j.ekir.2021. 09. 003. Go to original source...
  32. Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant [Internet]. 2012; 27(12): 4273-87. Available from: http://dx.doi.org/10.1093/ndt/gfs493. Go to original source... Go to PubMed...
  33. Emmett MA. Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis. [Internet]. Uptodate.com. [cited 2024 Aug 8]. Available from: https://www.uptodate.com/contents/etiology-and-diagnosis-of-distal-type-1-and-proximal-type-2-renal-tubular-acidosis.
  34. Mollerup CL. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ [Internet]. 2002; 325(7368): 807-807. Available from: http://dx.doi.org/10.1136/bmj.325.7368.807. Go to original source... Go to PubMed...
  35. Finkielstein VA. Strategies for preventing calcium oxalate stones. CMAJ [Internet]. 2006; 174(10): 1407-9. Available from: http://dx.doi.org/10.1503/cmaj.051517. Go to original source... Go to PubMed...
  36. Massey LK, Roman-Smith H, Sutton RAL. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc [Internet]. 1993; 93(8): 901-6. Available from: http://dx.doi.org/10.1016/0002-8223(93)91530-4. Go to original source... Go to PubMed...
  37. Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol [Internet]. 2010; 183(6): 2244-8. Available from: http://dx.doi.org/10.1016/j.juro.2010. 02. 007. Go to original source...
  38. Moe OW, Pearle MS, Sakhaee K. Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int [Internet]. 2011; 79(4): 385-92. Available from: http://dx.doi.org/10.1038/ki.2010.389. Go to original source... Go to PubMed...
  39. Mensenkamp AR, Hoenderop JGJ, Bindels RJM. Recent advances in renal tubular calcium reabsorption. Curr Opin Nephrol Hypertens [Internet]. 2006; 15(5): 524-9. Available from: http://dx.doi.org/10.1097/01.mnh.0000242179.38739.fb. Go to original source... Go to PubMed...
  40. Ruml LA, Pearle MS, Pak CYC. Medical therapy. Urol Clin North Am [Internet]. 1997; 24(1): 117-33. Available from: http://dx.doi.org/10.1016/s0094-0143(05)70358-x. Go to original source... Go to PubMed...
  41. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med [Internet]. 1986; 315(22): 1386-9. Available from: http://dx.doi.org/10.1056/nejm198611273152204. Go to original source... Go to PubMed...
  42. Kok DJ. Metaphylaxis, diet and lifestyle in stone disease. Arab J Urol [Internet]. 2012; 10(3): 240-9. Available from: http://dx.doi.org/10.1016/j.aju.2012. 03. 003. Go to original source...
  43. Daudon M, Bouzidi H, Bazin D. Composition and morphology of phosphate stones and their relation with etiology. Urol Res [Internet]. 2010; 38(6): 459-67. Available from: http://dx.doi.org/10.1007/s00240-010-0320-3. Go to original source... Go to PubMed...
  44. Pak CYC, Poindexter JR, Peterson RD, Heller HJ. Biochemical and physicochemical presentations of patients with brushite stones. J Urol [Internet]. 2004 [cited 2024 Aug 8]; 171(3): 1046-9. Available from: https://pubmed.ncbi.nlm.nih.gov/14767267/. Go to original source... Go to PubMed...
  45. Peerapen P, Thongboonkerd V. Kidney stone prevention. Adv Nutr [Internet]. 2023; 14(3): 555-69. Available from: http://dx.doi.org/10.1016/j.advnut.2023. 03. 002. Go to original source...
  46. Low phosphate diet. [Internet]. Cambridge University Hospitals. [cited 2024 Aug 8]. Available from: https://www.cuh.nhs.uk/patient-information/low-phosphate-diet.
  47. Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010; 23(Suppl 16): S165-9.
  48. Coe F. Brushite: Key to calcium stone prevention [Internet]. Uchicago.edu. [cited 2024 Aug 8]. Available from: https://kidneystones.uchicago.edu/2020/12/26/why-ss-for-calcium-phosphate-is-so-important.
  49. Klee LW, Brito CG, Lingeman JE. Clinical implications of brushite calculi. J Urol [Internet]. 1991; 145(4): 715-8. Available from: http://dx.doi.org/10.1016/s0022-5347(17)38432-x. Go to original source... Go to PubMed...
  50. Meng M. Struvite and staghorn calculi treatment & management [Internet]. Medscape.com. 2024 [cited 2024 Aug 8]. Available from: https://emedicine.medscape.com/article/439127-treatment.
  51. Gettman MT, Segura JW. Struvite stones: Diagnosis and current treatment concepts. J Endourol [Internet]. 1999; 13(9): 653-8. Available from: http://dx.doi.org/10.1089/end.1999. 13. 653. Go to original source...
  52. Karki N, Leslie SW. Struvite and Triple Phosphate Renal Calculi. StatPearls Publishing; 2023.
  53. Grases F, Costa-Bauzá A, Gomila I, Ramis M, García-Raja A, et al. Urinary pH and renal lithiasis. Urol Res [Internet]. 2012; 40(1): 41-6. Available from: http://dx.doi.org/10.1007/s00240-011-0389-3. Go to original source... Go to PubMed...
  54. Bose A, Bushinsky DA. Nephrolithiasis, nephrocalcinosis, and hypercalciuria. In: Chronic Renal Disease. Elsevier; 2020; p. 1103-22. Go to original source...
  55. Lubawy M, Formanowicz D. High-fructose diet-induced hyperuricemia accompanying metabolic syndrome-mechanisms and dietary therapy proposals. Int J Environ Res Public Health [Internet]. 2023; 20(4): 3596. Available from: http://dx.doi.org/10.3390/ijerph20043596. Go to original source... Go to PubMed...
  56. Yamanaka H. Alcohol ingestion and hyperuricemia. Nihon Rinsho [Internet]. 1996 [cited 2024 Aug 8]; 54(12). Available from: https://pubmed.ncbi.nlm.nih.gov/8976122/.
  57. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology [Internet]. 2000; 55(6): 825-30. Available from: http://dx.doi.org/10.1016/s0090-4295(99)00617-2. Go to original source... Go to PubMed...
  58. Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol [Internet]. 2006; 17(5): 1422-8. Available from: http://dx.doi.org/10.1681/asn.2005121246. Go to original source... Go to PubMed...
  59. Daudon M, Traxer O, Conort P, et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol [Internet]. 2006; 17(7): 2026-33. Available from: http://dx.doi.org/10.1681/asn.2006030262. Go to original source... Go to PubMed...
  60. Rodgers A, Allie-Hamdulay S, Jackson G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant [Internet]. 2006; 21(2): 361-9. Available from: http://dx.doi.org/10.1093/ndt/gfi211. Go to original source... Go to PubMed...
  61. Sadiq S, Cil O. Cystinuria: An overview of diagnosis and medical management. Turk Arch Pediatrics [Internet]. 2022; 57(4): 377-84. Available from: http://dx.doi.org/10.5152/turkarchpediatr.2022.22105. Go to original source... Go to PubMed...
  62. Cafasso J. Cystinuria [Internet]. Healthline. 2018 [cited 2024 Aug 8]. Available from: https://www.healthline.com/health/cystinuria.
  63. Kowalczyk NS, Zisman AL. Cystinuria: Review of a life-long and frustrating disease. Yale J Biol Med. 2021; 94(4): 681-6.
  64. Moussa M, Papatsoris AG, Abou Chakra M, Moussa Y. Update on cystine stones: current and future concepts in treatment. Intractable Rare Dis Res [Internet]. 2020; 9(2): 71-8. Available from: http://dx.doi.org/10.5582/irdr.2020.03006. Go to original source... Go to PubMed...
  65. Fjellstedt E, Denneberg T, Jeppsson J-O, Tiselius H-G. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol Res [Internet]. 2001; 29(5): 295-302. Available from: http://dx.doi.org/10.1007/s002400100200. Go to original source... Go to PubMed...
  66. Azer SM, Goldfarb DS. A summary of current guidelines and future directions for medical management and monitoring of patients with cystinuria. Healthcare (Basel) [Internet]. 2023; 11(5): 674. Available from: http://dx.doi.org/10.3390/healthcare11050674. Go to original source... Go to PubMed...
  67. Safranow K. Defekt fosforybozylotransferazy adeninowej (APRT) - molekularne i kliniczne aspekty dihydroksyadeninurii. Postępy Higieny i Medycyny Doświadczalnej 1998; 52(1): 89-104.
  68. Bollee G. Adenine phosphoribosyltransferase deficiency [Internet]. Orpha.net. [cited 2024 Aug 8]. Available from: https://www.orpha.net/en/disease/detail/976?name=2,8-dihydroxyadenine%20urolithiasis.
  69. Mraz M, Hurba O, Bartl J, et al. Modern diagnostic approach to hereditary xanthinuria. Urolithiasis [Internet]. 2015; 43(1): 61-7. Available from: http://dx.doi.org/10.1007/s00240-014-0734-4. Go to original source... Go to PubMed...
  70. Marzuillo P, Guarino S, Apicella A, et al. Why we need a higher suspicion index of urolithiasis in children. J Pediatr Urol [Internet]. 2017; Available from: http://dx.doi.org/10.1016/j.jpurol.2016. 12. 021. Go to original source...
  71. Sebesta I, Stiburkova B. Hereditary xanthinuria [Internet]. Orpha.net. [cited 2024 Aug 8]. Available from: https://www.orpha.net/en/disease/detail/3467?name=xathinuria.
  72. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol [Internet]. 2017; 198(4): 858-63. Available from: http://dx.doi.org/10.1016/j.juro.2017. 03. 124. Go to original source...

Return to the content



Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.


Odejít Vstoupit